Centiva Capital, LP Bio Techne Corp Transaction History

Centiva Capital, LP

$5.76 Billion
Q2 2025

A detailed history of Centiva Capital, LP transactions in Bio Techne Corp stock. As of the latest transaction made, Centiva Capital, LP holds 9,841 shares of TECH stock, worth $519,900. This represents 0.01% of its overall portfolio holdings.

Number of Shares

9,841

Previous 15,447 36.29%

Holding current value

$519,900

Previous $905,000 44.09%

% of portfolio

0.01%

Previous 0.03%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	SELL	$46.66 - $58.38 $261,575 - $327,278	-5,606 Reduced 36.29%	9,841 $506,000
Q1 2025 May 15, 2025	BUY	$58.47 - $78.75 $903,186 - $1.22 Million	15,447 New	15,447 $905,000
Q2 2024 Aug 14, 2024	BUY	$62.12 - $84.15 $985,098 - $1.33 Million	15,858 Added 148.89%	26,509 $1.9 Million
Q1 2024 May 15, 2024	BUY	$65.98 - $77.09 $702,752 - $821,085	10,651 New	10,651 $749,000
Q3 2023 Nov 14, 2023	BUY	$67.52 - $89.42 $7,494 - $9,925	111 Added 3.15%	3,640 $247,000
Q2 2023 Aug 14, 2023	SELL	$73.76 - $85.98 $159,247 - $185,630	-2,159 Reduced 37.96%	3,529 $288,000
Q1 2023 May 15, 2023	BUY	$71.62 - $86.62 $407,374 - $492,694	5,688 New	5,688 $421,000
Q4 2021 Feb 14, 2022	SELL	$456.15 - $525.06 $465,729 - $536,086	-1,021 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$444.87 - $538.88 $847,922 - $1.03 Million	-1,906 Reduced 65.12%	1,021 $494,000
Q2 2021 Aug 16, 2021	BUY	$387.35 - $450.26 $1.13 Million - $1.32 Million	2,927 New	2,927 $1.32 Million
Q4 2020 Feb 16, 2021	SELL	$246.9 - $321.87 $579,968 - $756,072	-2,349 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$232.22 - $282.96 $545,484 - $664,673	2,349 New	2,349 $582,000
Q2 2020 Aug 14, 2020	SELL	$185.43 - $279.56 $670,514 - $1.01 Million	-3,616 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$161.17 - $221.51 $582,790 - $800,980	3,616 New	3,616 $686,000

Others Institutions Holding TECH

# of Institutions

607

Shares Held

160M

Call Options Held

221K

Put Options Held

70.3K

View Full List

About BIO-TECHNE Corp

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.07B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

More about TECH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Centiva Capital, LP with notifications on news.

Account

Centiva Capital, LP Bio Techne Corp Transaction History